Biotechnology Value Trading Fund OS LP, 10% Owner at FIVE PRIME THERAPEUTICS, INC. (FPRX), bought 525,070 shares at $3.75 ($2.0M) on 2019-10-07, disclosed to the SEC on 2019-10-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 14,242 | $53K | 2.7% |
| 2 | $3.75 | 24,425 | $92K | 4.7% |
| 3 | $3.75 | 80,821 | $303K | 15.4% |
| 4 | $3.75 | 98,333 | $369K | 18.7% |
| 5 | $3.75 | 138,609 | $520K | 26.4% |
| 6 | $3.75 | 168,640 |
| $632K |
| 32.1% |
| Total | $3.75 avg | 525,070 | $2.0M | 100% |
| Filing → |
| RPTX | BUY | 2023-11-03 | $5.6M | — | Filing → |
| OLMA | BUY | 2023-09-14 | $29.6M | — | Filing → |
| OLMA | BUY | 2022-06-14 | $1.6M | — | Filing → |